POSEIDON – positive interim results in Q4 2020; additional interim results expected in Q2 2021 and primary endpoint in Q2 2022
RED DESERT – positive interim results in Q4 2020; top-line data expected in Q2 2021
Successful equity placements extend cash runway into Q2 2022
Conference call with live
Ghent, BELGIUM – 17 March 2021
– Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces its financial results for the year ended 31 December 2020, and provides a business update and an outlook for the remainder of 2021.
Ian Crosbie, Chief Executive Officer at Sequana Medical, commented: “We made outstanding progress in 2020, delivering very promising clinical data in both our focus areas, liver disease / NASH
Support HB-5067 to stop non-consensual pelvic/prostate exams under anesthesia
Latest status as of March 11, 2021
Imagine you are a patient who is undergoing abdominal surgery, perhaps you have a gynecological or prostate issue. Naturally you gravitate to the best hospital in your network or you follow your physician. Many physicians wear two hats they’re both caretakers and teachers.
For you, this means that medical students may be there, observing. But many will do far more. As the Yale University School of Medicine explains, this “involves hands-on teaching of invasive clinical skills, such as the pelvic exam.” Pelvic exam is performed by inserting two gloved fingers into a vagina to assess gynecological health of a woman.
Sequana Medical Announces 2020 Full Year Results and 2021 Outlook benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
The Schools of Medicine at Yale and University of Pittsburgh are joining forces with Three Lakes Foundation to accelerate a cure for pulmonary fibrosis
News provided by
Share this article
Share this article
CHICAGO, March 17, 2021 /PRNewswire/ Three Lakes Foundation (TLF) has announced that it has selected Yale University School of Medicine and the University of Pittsburgh School of Medicine to join the
Three Lakes Consortium for Pulmonary Fibrosis (TLC4PF). Together, they will focus on advancing disease understanding with the goal to accelerate new treatments and curing this devastating lung condition.
Naftali Kaminski, MD, Yale School of Medicine and Melanie Königshoff, MD, University of Pittsburgh School of Medicine are joining forces with Three Lakes Foundation
Sequana Medical Announces 2020 Full Year Results and 2021 Outlook apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.